Sonova has had a PPA conducted for the acquisition of AudioNova
In September 2016, Sonova, the world’s leading provider of hearing solutions, acquired AudioNova. Subsequent to the transaction, a purchase price allocation (PPA) was conducted for accounting purposes.
Sonova, headquartered in Stäfa, Switzerland, is the leading provider of innovative hearing care solutions. The group operates through its core business brands Phonak, Unitron, Hansaton and Advanced Bionics. Sonova offers its customers one of the most comprehensive product portfolios in the industry – from hearing instruments to cochlear implants and wireless communication solutions. Founded in 1947, the group is currently present in over 100 countries across the globe and has a workforce of over 14,000 dedicated employees.
AudioNova is one of Europe’s leading hearing aid retailers and service providers. With its highly qualified staff, including 1,600 acousticians, the company assists its clients with the selection of the best hearing solution for their needs, ensuring actual use through continuous support, thus improving quality of life through better hearing. In addition to AudioNova, the group also operates under brands such as Audium, AuditionSanté, Boots Hearingcare, Connect Hearing, Fiebing, Geers, Hansaton, Lapperre, Lindacher, Schoonenberg, Triton and Vitakustik.
Oaklins' team in Switzerland advised Sonova during the post-transaction phase and produced a PPA report in accordance with IFRS 3. The report contained the allocation of the consideration paid to all identifiable assets acquired and liabilities assumed.
Thomas Lenz
Senior Manager Corporate Controlling, Sonova
Talk to the deal team
Related deals
MEDIK Hospital Design Group has been acquired by STERIS
The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.
Learn morebioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG
Rancoderm GmbH has been acquired by Rose Investment- und Beteiligungs AG to secure the funding required for the final development and market approval of its medical device DermaPro. The acquisition will enable Rancoderm to bring DermaPro to market readiness and launch it as a certified medical product for broad distribution.
Learn moreSLT has been acquired by Indutrade
SLT S.r.l. has been acquired by Indutrade AB and will be integrated into the group’s life science business area. The transaction is Indutrade’s fifth acquisition in 2025 and is expected to have a marginally positive impact on the group’s earnings per share.
Learn more